XM does not provide services to residents of the United States of America.

Tech shares lead Japan's Nikkei higher in choppy session



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Tech shares lead Japan's Nikkei higher in choppy session</title></head><body>

By Brigid Riley

TOKYO, Oct 21 (Reuters) -Japan's Nikkei share average rose in a choppy session on Monday, as gains in technology stocks lifted the benchmark index, while caution ahead of a domestic election and corporate earnings weighed on sentiment.

The Nikkei .N225 managed to turn around after starting in the red, rising 0.3% to 39,110.95 by the midday break, while the broader Topix .TOPX was up 0.04% at 2,689.99.

Domestic tech shares followed their U.S. peers higher after an earnings-driven jump in Netflix shares and broader gains across tech stocks on Friday. .N

The Dow Jones Industrial Average and S&P 500 chalked up record closing highs on Friday, with the Nasdaq also in positive territory, thanks to the tech bump.

Nikkei heavyweight chip-testing equipment maker Advantest 6857.T was up 2.2% to offer the biggest lift, followed by chip-making equipment giant Tokyo Electron 8035.T, adding 1.1%.

But the index struggled for momentum outside of tech shares, which analysts attributed to caution before more company earnings announcements later this week.

A general election will also be held in Japan on Oct. 27, where it remains to be seen whether the nation's ruling party, the Liberal Democratic Party (LDP), will succeed in winning the 233 seats needed to keep a lower-house majority by itself.

"It seems like investors are refraining from active trading in anticipation of these events", creating a heavy upward resistance, said Masahiro Ichikawa, chief market strategist at Sumitomo Mitsui DS Asset Management.

If the LDP fails to retain a majority in the upcoming election, that could "heighten uncertainty and potentially lead to increased volatility in the market", he added.

Among other major decliners, Uniqlo parent firm Fast Retailing 9983.T edged down 0.2%, along with telecoms company KDDI 9433.T slipping 0.8%, and pharmaceutical firm Daiichi Sankyo 4568.T losing 1.3%.

Of the Nikkei's 225 constituents, 104 advanced while 118 declined.





Reporting by Brigid Riley; Editing by Rashmi Aich

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.